FI963288A0 - Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena - Google Patents

Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena

Info

Publication number
FI963288A0
FI963288A0 FI963288A FI963288A FI963288A0 FI 963288 A0 FI963288 A0 FI 963288A0 FI 963288 A FI963288 A FI 963288A FI 963288 A FI963288 A FI 963288A FI 963288 A0 FI963288 A0 FI 963288A0
Authority
FI
Finland
Prior art keywords
anticoagulant
fibrin
specific antibody
antibody
specific
Prior art date
Application number
FI963288A
Other languages
English (en)
Swedish (sv)
Other versions
FI963288A (fi
Inventor
Paul E Gargan
Original Assignee
American Biogenetic Sciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Biogenetic Sciences filed Critical American Biogenetic Sciences
Publication of FI963288A0 publication Critical patent/FI963288A0/fi
Publication of FI963288A publication Critical patent/FI963288A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI963288A 1994-02-24 1996-08-23 Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena FI963288A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/204,015 US5487892A (en) 1994-02-24 1994-02-24 Method for treating thrombotic disease using a fibrin specific monoclonal antibody
PCT/US1995/001825 WO1995022986A1 (en) 1994-02-24 1995-02-21 Fibrin-specific antibody for use as an antithrombotic agent

Publications (2)

Publication Number Publication Date
FI963288A0 true FI963288A0 (fi) 1996-08-23
FI963288A FI963288A (fi) 1996-08-23

Family

ID=22756260

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963288A FI963288A (fi) 1994-02-24 1996-08-23 Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena

Country Status (26)

Country Link
US (1) US5487892A (fi)
EP (1) EP0749320A4 (fi)
JP (1) JPH09509429A (fi)
KR (1) KR970701063A (fi)
CN (1) CN1146157A (fi)
AU (1) AU708897B2 (fi)
BG (1) BG62476B1 (fi)
BR (1) BR9506949A (fi)
CA (1) CA2183953A1 (fi)
CZ (1) CZ246496A3 (fi)
FI (1) FI963288A (fi)
GE (1) GEP20002257B (fi)
HU (1) HUT76536A (fi)
LT (1) LT4192B (fi)
LV (1) LV11784B (fi)
MD (1) MD1521G2 (fi)
MX (1) MX9603602A (fi)
NO (1) NO963497L (fi)
NZ (1) NZ281481A (fi)
PL (1) PL316005A1 (fi)
RU (1) RU2152801C2 (fi)
SG (1) SG53279A1 (fi)
SK (1) SK108496A3 (fi)
TJ (1) TJ301B (fi)
UA (1) UA41984C2 (fi)
WO (1) WO1995022986A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5453359A (en) * 1988-06-13 1995-09-26 American Biogenetic Sciences, Inc. Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers
US5817768A (en) * 1995-06-07 1998-10-06 The New York Blood Center, Inc. Monospecific antibodies against a subunit of fibrinogen
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) * 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
IL134828A0 (en) * 2000-03-01 2001-05-20 Eship 4U Com Inc System for delivery and receipt of dispatches especially useful for e-commerce
US8658773B2 (en) 2011-05-02 2014-02-25 Immunomedics, Inc. Ultrafiltration concentration of allotype selected antibodies for small-volume administration
US20050181451A1 (en) * 2004-02-12 2005-08-18 Bates Harold M. Detection of asymptomatic coronary artery disease using atherogenic proteins and acute phase reactants
JP4088328B2 (ja) * 2004-12-28 2008-05-21 第一化学薬品株式会社 抗ヒト可溶性フィブリンモノクローナル抗体及び当該抗体を用いる免疫学的測定方法
AU2013302696B9 (en) 2012-08-14 2018-08-09 Ibc Pharmaceuticals, Inc. T-cell redirecting bispecific antibodies for treatment of disease
BR112015013444B1 (pt) 2012-12-13 2022-11-01 Immunomedics, Inc Uso de um imunoconjugado
CN110563258A (zh) * 2019-09-06 2019-12-13 广东石油化工学院 一种猪场废水厌氧产氢与达标排放处理方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572125B2 (en) * 1983-03-17 1988-05-05 Mabco Limited Monoclonal antibodies with specificity for crosslinked fibrin and their diagnotic uses
US4722903A (en) * 1983-11-14 1988-02-02 New York Blood Center, Inc. Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JP2635343B2 (ja) * 1986-04-14 1997-07-30 ザ・ジェネラル・ホスピタル・コーポレーション ヘテロ二官能性抗体および利用方法
AU7912887A (en) * 1986-08-25 1988-03-24 American Biogenetic Sciences, Inc. Monoclonal antibodies to fibrin
DE3701812A1 (de) * 1987-01-22 1988-08-04 Max Planck Gesellschaft Fibrinspezifischer antikoerper, verfahren zur seiner herstellung und seine verwendung
US5223410A (en) * 1988-06-13 1993-06-29 American Biogenetic Sciences, Inc. Method for production of antibodies utilizing an antigen-free animal
SG50681A1 (en) * 1988-06-13 1998-07-20 American Biogenetic Sciences Method for the production of monoclonal antibodies utilizing a germfree animal
US5091512A (en) * 1988-06-13 1992-02-25 American Biogenetic Sciences, Inc. Fibrinogen-specific monoclonal antibody
US5120834A (en) * 1988-06-13 1992-06-09 American Biogenetic Sciences, Inc. Fibrin-specific monoclonal antibody
US5206140A (en) 1988-06-24 1993-04-27 Research Corporation Technologies, Inc. Assay for soluble crosslinked fibrin polymers
CA2052283A1 (en) * 1990-09-27 1992-03-28 Edgar Haber Recombinant hybrid immunoglobulin molecules and method of use

Also Published As

Publication number Publication date
EP0749320A1 (en) 1996-12-27
UA41984C2 (uk) 2001-10-15
LT4192B (en) 1997-07-25
NZ281481A (en) 1998-07-28
MD1521F2 (en) 2000-08-31
LT96140A (en) 1997-03-25
KR970701063A (ko) 1997-03-17
EP0749320A4 (en) 1997-06-18
FI963288A (fi) 1996-08-23
NO963497D0 (no) 1996-08-22
SK108496A3 (en) 1997-10-08
HU9602337D0 (en) 1996-10-28
AU708897B2 (en) 1999-08-12
MX9603602A (es) 1997-05-31
LV11784A (lv) 1997-06-20
LV11784B (en) 1997-12-20
US5487892A (en) 1996-01-30
SG53279A1 (en) 1998-09-28
WO1995022986A1 (en) 1995-08-31
NO963497L (no) 1996-10-16
HUT76536A (en) 1997-09-29
CA2183953A1 (en) 1995-08-31
RU2152801C2 (ru) 2000-07-20
MD1521G2 (ro) 2001-03-31
PL316005A1 (en) 1996-12-23
AU1843495A (en) 1995-09-11
BG62476B1 (bg) 1999-12-30
CN1146157A (zh) 1997-03-26
CZ246496A3 (en) 1997-04-16
BR9506949A (pt) 1997-09-23
JPH09509429A (ja) 1997-09-22
GEP20002257B (en) 2000-10-25
BG100863A (en) 1997-08-29
TJ301B (en) 2001-08-06
MD960334A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
DK0837927T3 (da) Anti-CD80-antistoffer
DK145493D0 (da) Antistof
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
DE69501178T2 (de) Optisches Messtechnikverfahren
DE59510271D1 (de) Messfühler
NO961887L (no) -adrenergiske agonister
DE69514851D1 (de) Interatomares Messverfahren
FI963288A0 (fi) Fibriinispesifinen vasta-aine käytettäväksi veritulppia estävänä aineena
FI941867A0 (fi) Reagenssiallas
NO953708D0 (no) Tribologisk anordning
DE29514506U1 (de) Objektträger-Eindeckautomat
FI963862A0 (fi) Analyyttinen ilmaiseminen
DE9412629U1 (de) Kleinbank
DE9407713U1 (de) Aschenbecher
DE9416307U1 (de) Prüfvorrichtung
FI944865A0 (fi) Biospecifinen määritysmenetelmä
DE29500356U1 (de) Probennehmer
DE9405878U1 (de) Rhenchodepressive Substanz
DE9401796U1 (de) Meßbecher
FI941591A0 (fi) Biospesifik bestaemningsmetod
SE9002605D0 (sv) Antikroppssubstans
KR960011930U (ko) 허리를 재는 간편한 측정법
DE9417084U1 (de) Meßbrille
FI1447U1 (fi) Provtagare
SE9701168D0 (sv) Methods for determining canmcer antigens